This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Leukemia
and you are
between 15 and 65
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at gene expression in tissue from patients with acute lymphoblastic leukemia enrolled in clinical trial ECOG-2993.

Provided treatments

  • Genetic: microarray analysis
  • Genetic: reverse transcriptase-polymerase chain reaction
  • Other: flow cytometry
Tris trial is registered with FDA with number: NCT00898261. The sponsor of the trial is ECOG-ACRIN Cancer Research Group and it is looking for 137 volunteers for the current phase.
Official trial title:
Genetic Risk Classes in Adult Acute Lymphocytic Leukemia